Viewing Study NCT03325166


Ignite Creation Date: 2025-12-24 @ 4:35 PM
Ignite Modification Date: 2026-02-20 @ 12:47 AM
Study NCT ID: NCT03325166
Status: TERMINATED
Last Update Posted: 2022-08-10
First Post: 2017-10-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Pembrolizumab and Magnetic Resonance Imaging With Ferumoxytol in Treating Patients With Non-small Cell Lung Cancer and Brain Metastases
Sponsor: OHSU Knight Cancer Institute
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-11-03
Start Date Type: ACTUAL
Primary Completion Date: 2021-03-01
Primary Completion Date Type: ACTUAL
Completion Date: 2021-03-01
Completion Date Type: ACTUAL
First Submit Date: 2017-10-06
First Submit QC Date: None
Study First Post Date: 2017-10-30
Study First Post Date Type: ACTUAL
Results First Submit Date: 2022-05-16
Results First Submit QC Date: None
Results First Post Date: 2022-08-10
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-07-14
Last Update Post Date: 2022-08-10
Last Update Post Date Type: ACTUAL